期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

帕金森病外周血生物标记物的研究及评价 被引量：2

Studies and assessment of peripheral blood biomarkers in patients with Parkinson＇s disease
原文传递
导出
摘要 PD是一种年龄相关性神经元退行性变．典型病变表现为黑质多巴胺能神经元和蓝斑去甲肾上腺素能神经元变性．路易小体（Lewybody，LB）形成为其特征性病理改变。PD起病隐匿，早期无明显临床症状，晚期可表现为运动系统障碍。
作者 张家义 李晓莉 刘承伟
机构地区 桂林医学院附属医院病理科
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2012年第1期95-97,共3页 Chinese Journal of Neuromedicine
关键词 帕金森病 生物标记物 早期诊断 生物组学 Parkinson＇s disease Biomarkers Early diagnosis Biological genomics
分类号 R742.5 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献41

  • 1Halliday GM,Mccann H.The progression of pathology in Parkinson's disease[J].Ann N Y Acad Sci,2010,1184(2):188-195.
  • 2Schapira AV.Etiology and pathogenesis of parkinson disease[J].Neurol Clin,2009,27(3):583-603.
  • 3Chen CM,Liu JL,Wu YR,et al.Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease[J].Neurobiol Dis,2009,33(3):429-435.
  • 4Akazawa YO,Saito Y,Hamakubo T,et al.Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals[J].Neurosci Lett,2010,483(3):201-205.
  • 5Maita C,Tsuji S,Yabe I,et al.Secretion of DJ-1 into the serum of patients with Parkinson's disease[J].Neurosci Lett,2008,431 (1):86-89.
  • 6Ascherio A,Lewitt PA,Xu K,et al.Urate as a predictor of the rate of clinical decline in Parkinson disease[J].Arch Neurol,2009,66(12):1460-1468.
  • 7Mateo I,Infante J,Sanchez-Juan P,et al.Serum heine oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease[J].Acta Neurol Scand,2010,121 (2):136-138.
  • 8Andreadou E,Nikolaou C,Gournaras F,et al.Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration[J].Clin Neurol Neurosurg,2009,111(9):724-728.
  • 9Schwarzschild MA,Marek K,Eberly S,et al.Serum urate and probability of dopaminergic deficit in early "Parkinson's disease"[J].Mov Disord,2011,26(10):1864-1868.
  • 10Obeid R,Schadt A,Dillmann U,et al.Methylation status and neurodegenerative markers in Parkinson disease[J]. Clin Chem,2009,55(10):1852-1860.

二级参考文献28

  • 1Mizuno Y,Hattori N,Kiibo S,et al.Progress in the pathogenesis and genetics of Parkinson's disease[J].Philos Trans R Soc Lond B Biol Sci,2008,363(1500):2215-2227.
  • 2Farrer MJ.Genetics of Parkinson disease:paradigm shifts and future prospects[J].Nat Rev Genet,2006,7(4):306-318.
  • 3Thomas B,Beal MF.Parkinson's disease[J].Hum Mol Genet,2007,16(2):183-194.
  • 4Kann MG.Protein interactions and disease:computational approaches to uncover the etiology of diseases[J].Brief Bioinform,2007,8(5):333-346.
  • 5Brown KR,Jurisica I.Online predicted human interaction database[J].Bioinformatics,2005,21(9):2076-2082.
  • 6Chaurasia G,Iqbal Y,Hanig C,et al.UniHI:an entry gate to the human protein interactome[J].Nucleic Acids Res,2007,35(Database issue):D590-594.
  • 7Chen JY,Shen C,Sivachenko AY.Mining Alzheimer disease relevant proteins from integrated protein interactome data[J],Pac Symp Biocomput,2006:367-378.
  • 8Chen JY,Sivachenko AY.Data mining in protein interactomics.Six computational research challenges and opportunities[J].IEEE Eng Med Biol Mag,2005,24(3):95-102.
  • 9Bruford EA,Lush MJ,Wright MW,et al.The HGNC Database in 2008:a resource for the human genome[J].Nucleic Acids Res,2008,6(Database issue):D445-448.
  • 10Pridgeon JW,Olzmann JA,Chin LS,et al.PINK1 protects against oxidative stress by phosphorylating mitochondriai chaperone TRAP1[J].PLoS Biol,2007,5(7):e172.

共引文献4

同被引文献31

  • 1Riederer P, Konradi C, Hebenstreit G, et al. Neurochemical perspectives to the function of monoamine oxidase [J]. Acta Neurol Scand Suppl, 1989, 80 (126): 41-45.
  • 2Antkiewicz-Michaluk L. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines[J]. Pol J Pharmacol, 2002, 54(6): 567-572.
  • 3Adamczyk A, Kazmierczak A, Strosznajder JB. a-synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes: Relationship to nitric oxide [J]. Neurochem Int, 2006, 49(4): 407-412.
  • 4Periquet M, Fulga T, Myllykangas L, et al. Aggregated a-synuclein mediates dopaminergic neurotoxicity in vivo[J]. J Neurosci, 2007, 27(12): 3338-3346.
  • 5Hughes AJ, Daniel SE, K.ilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases [J]. J Neurol Neurosurg Psychiatry, 1992, 55(3): 181-184.
  • 6Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson' s disease [J]. Nat Genet, 2009, 41 (12): 1303-1307.
  • 7Spencer CC, Plagnol V, Strange A, et al. Dissection of the genetics of Parkinson's disease identifies an additional association 5 'of SNCA and multiple associated haplotypes at 17q21 [J]. Hum MolGenet, 2011, 20(2): 345-353.
  • 8Pan F, Dong H, Ding H, et al. SNP rs356219 of the a-synuclein (SNCA) gene is Associated with Parkinson ' s disease in a Chinese Han population [J]. Parkinsonsim Relat Disord, 2012, 18 (5): 632-634.
  • 9Mizuta I, Tsunoda T, Satake W, et al. Calbindin I, fibroblast growth factor 20, and a-Synuclein in sporadic Parkinson's disease [J]. Hum Genet, 2008, 124(1): 89-94.
  • 10Mueller JC, Fuchs J, Hofer A, et al. Multiple regions of a-synuclein are associated with Parkinson's disease [J]. Ann Neurol, 2005, 57 (4): 535-541.

引证文献2

二级引证文献3

中华神经医学杂志
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部